Results 111 to 120 of about 1,671,881 (203)

The Impact of Polymers in Amorphous Solid Dispersion on the Bioavailability of Sulfonylureas and Meglitinides. [PDF]

Drug Des Devel Ther
Aulifa DL, Wibisono TTDW, Ningsih JD, Christy GDAB, Pertiwi DS, Praja HM, Gazzali AM, Amaliah S, Budiman A.   +8 more
europepmc   +1 more source

Screening of binding by antidiabetic drugs to normal vs AGE-modified human serum albumin through covalent immobilization and microscale affinity chromatography. [PDF]

J Chromatogr B Analyt Technol Biomed Life Sci
Woolfork AG, Rahman MM, Graham LM, Hage DS.   +3 more
europepmc   +1 more source

Influences of Fasting on Elimination of Sulfonylurea Compounds from Plasma in Rabbits

YAKUGAKU ZASSHI, 1983
S, Tsukiai, H, Fukuchi, M, Yoshida, M, Kumagai, T, Kitaura, S, Arai, N, Yata   +6 more
openaire   +3 more sources

Design, <i>in Vitro</i> Biological Activities and Molecular Dynamics Simulations of Novel Chalcone and Pyrazole Derivatives Targeting α‑Glucosidase and PPAR‑γ as Antidiabetic Agents. [PDF]

ACS Omega
Kurşun Aktar BS, Taşdemir D, Sağlam E, Kaya S, Yılmaz GT, Şahin Yağlioğlu A, Oruç-Emre EE.   +6 more
europepmc   +1 more source

Determination of Fluorinated Pesticide Residues and Their Selected Transformation Products in High-Water-Content Foods Using Complementary LC-MS/MS and GC-MS/MS Methods. [PDF]

Foods
Wenio I, Kwiatkowski D, Dawidziak DM, Derewiaka D, Majewska E, Bartosiewicz I.   +5 more
europepmc   +1 more source

Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk. [PDF]

J Diabetes Investig
Soga R, Torimoto K, Uemura F, Okada Y, Nakayamada S.   +4 more
europepmc   +1 more source

Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]

BMJ Open Diabetes Res Care
Sklepinski S, Ratzki-Leewing AA, Herrin J, Swarna KS, Deng Y, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG.   +15 more
europepmc   +1 more source

Effectiveness of empagliflozin in reducing hypoglycemic events as compared to sulfonylurea in type 2 diabetes patients during fasting in Ramadan: a single-center study. [PDF]

BMC Endocr Disord
Kiran Z, Fatima N, Baloch AA, Shaikh KUS, Hasan SM, Khan MU.   +5 more
europepmc   +1 more source

Insulin autoimmune hypoglycemia unmasking monoclonal gammopathy in type 2 diabetes. [PDF]

JCEM Case Rep
Prasad S, Sharma A, Parmar V, Jindal T, Kothia D, Bavaria D.   +5 more
europepmc   +1 more source

Identifying high-risk combinations of metformin during COVID-19. [PDF]

PLoS One
Dimnjaković J, Buble T, Poljičanin T, Brborović H, Brađašević E, Brborović O.   +5 more
europepmc   +1 more source